ALDH1A1 and neoplasm: To validate the alterations in ALDH-1 levels observed in vitro in response to DOX, PIP, and their combination, immunoreactivity against ALDH-1 was estimated using immunohistochemistry (Fig. 7A) in tumor tissue sections and subsequently confirmed using ELISA in tumor tissue homogenates.